نتایج جستجو برای: warfarin reversal

تعداد نتایج: 44044  

2016
Ioannis D. Siasios Kunal Vakharia Kevin J. Gibbons Vassilios G. Dimopoulos

BACKGROUND Iatrogenic or spontaneous spinal hematomas are rarely seen and present with multiple symptoms that can be difficult to localize. Most spontaneous spinal hematomas are multifactorial, and the pathophysiology is varied. Here, we present a case of a scattered, multicomponent, combined subdural and epidural spinal hematoma that was managed conservatively. CASE DESCRIPTION A 38-year-old...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2008
Guoying Tai Leslie J Dickmann Nicholas Matovic James J DeVoss Elizabeth M J Gillam Allan E Rettie

A common feature of many CYP2C9 ligands is their weak acidity. As revealed by crystallography, the structural basis for this behavior involves a charge-pairing interaction between an anionic moiety on the substrate and an active site R108 residue. In the present study we attempted to re-engineer CYP2C9 to better accept basic ligands by charge reversal at this key residue. We expressed and purif...

2016
Sangeeta Ramanan Jude Chapman-Wardy Roy Watson

A 43-year-old woman presented with severe anaemia secondary to menorrhagia. Pelvic ultrasound showed a large intramural posterior fundal fibroid. Hysteroscopy showed the fibroid distorting the endometrial cavity, precluding Mirena® device insertion. As she was initially hesitant to have a hysterectomy, medical management with the oral contraceptive pill (OCP) and tranexamic acid was instituted,...

2012
MingSong Wang XiLong Lang ShiTao Cui Ke Fei LiangJian Zou Jia Cao LiangXu Wang ShengHui Zhang XinTian Wu YiLing Wang Qiang Ji

BACKGROUND The polymorphisms of VKORC1 and CYP2C9 play increasingly important roles in the inter-individual variability in warfarin dose. This study aimed to evaluate the feasibility of clinical application of pharmacogenetic-based warfarin-dosing algorithm in patients of Han nationality with rheumatic heart disease after valve replacement in a randomized and controlled trial. METHODS One hun...

Journal: :The Journal of clinical investigation 1974
R J Lewis W F Trager K K Chan A Breckenridge M Orme M Roland W Schary

An examination of the metabolic fate of the R and the S isomers of warfarin revealed that the two isomers were metabolized by different routes. R warfarin was oxidized to 6-hydroxywarfarin and was reduced to the (R,S) warfarin alcohol. In contrast, S warfarin was oxidized to 7-hydroxywarfarin and was reduced to the (S,S) warfarin alcohol. S warfarin was also oxidized to 6-hydroxywarfarin. These...

Journal: :Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique 2013
S Aubrey Stoch Rose Witter David Hrenuik Chengcheng Liu Stefan Zajic Anish Mehta Patricia Chandler Denise Morris Hongwei Xue Andrew Denker John A Wagner

BACKGROUND Warfarin is an anticoagulant with a narrow therapeutic index that is involved in a number of drug-drug interactions. OBJECTIVES This study evaluates the potential effect of odanacatib (a cathepsin K inhibitor in development for the treatment of osteoporosis) on the pharmacokinetics and pharmacodynamics of warfarin. METHODS In a randomized, open-label, two-period fixed-sequence de...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2007
Mayumi Ishizuka Fumie Okajima Tsutomu Tanikawa Heewon Min Kazuyuki D Tanaka Kentaro Q Sakamoto Shoichi Fujita

Wild roof rats (Rattus rattus) live in proximity to human habitats, and they may carry numerous pathogens of infectious diseases. Pest control is important for public health, and warfarin is a commonly used rodenticide worldwide. However, continual use of warfarin may cause drug resistance in rodents and lead to failure of their control, especially in urbanized areas. In warfarin-resistant rats...

Journal: :Biological & pharmaceutical bulletin 2015
Satoshi Yamaori Ken Takami Ayaka Shiozawa Kanako Sakuyama Naoki Matsuzawa Shigeru Ohmori

Iguratimod is a novel disease-modifying antirheumatic drug. A blue letter (safety advisory) for drug interaction between iguratimod and warfarin was issued by the Ministry of Health, Labour and Welfare of Japan in May 2013. Iguratimod may affect warfarin metabolism catalyzed by CYP. However, it is not clear whether iguratimod inhibits warfarin oxidation. This study was performed to investigate ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید